Reconstitution is the process of adding a liquid diluent to a vial of freeze-dried peptide powder to make a solution that can be measured and injected. Knowing how to reconstitute peptides matters in exactly one situation: a prescription arrives as a powder vial plus a separate diluent vial, with instructions to mix the two before first use. Many prescription peptide products never require it at all — compounding pharmacies frequently dispense solutions already mixed, dated, and ready to use. This article explains the standard technique, the reasoning behind each step, and the storage rules that follow — and where the instructions dispensed with your specific product override anything written here.
Why peptides ship as a powder
Peptides are shipped as freeze-dried powder because the solid form is far more stable than a solution — chemical degradation effectively begins the moment the peptide dissolves. The freeze-drying process, called lyophilization, removes water under vacuum and leaves a solid cake, often formulated with stabilizing sugars such as sucrose or trehalose that protect the peptide's structure by replacing water's hydrogen bonds and forming a protective glass around the molecules (Karunnanithy 2024). Formulation details matter even here: a 2025 calorimetry study using glucagon as a model found lactose outperformed trehalose at delaying aggregation during freezing, and that higher stabilizer-to-peptide ratios consistently reduced aggregation (Zäh 2025).
The flip side is that everything after the powder stage is in the handler's hands. A 2016 consensus paper gives storage and handling recommendations for synthetic peptide standards used in mass-spectrometry assays; it does not evaluate patient reconstitution of prescription injections. Careful technique is not fussiness; it is the whole game.
Read the pharmacy label before anything else
The product-specific instructions dispensed by your pharmacy govern everything in this article. Prescription peptide products through Promise are compounded — prepared for an individual prescription by a licensed U.S. compounding pharmacy, rather than sold as FDA-approved mass-market products — and the pharmacy sets the diluent, the volume, the beyond-use date, and the storage conditions for the exact formulation it prepared. (For how that preparation process works, see how compounded medications are made.)
Two practical consequences:
- Your product may arrive pre-mixed. Compounding pharmacies often dispense peptides as ready-to-use solutions with the concentration and beyond-use date printed on the label. If yours does, you never reconstitute anything — skip to storage.
- If the label disagrees with a general guide, the label wins. The pharmacy chose its diluent and dating for the specific formulation in your vial, and general rules of thumb do not overrule it.
Bacteriostatic water vs. sterile water
Bacteriostatic water is sterile water for injection containing benzyl alcohol as an antimicrobial preservative; because the preservative suppresses bacterial growth between uses, an opened vial supports multiple entries for up to 28 days. Sterile water for injection contains no preservative, so once the vial is punctured it is a single-use diluent — the USP-consistent practice is to use it immediately and discard the remainder, not to stretch it across sessions. The distinction matters because a dissolved peptide is a good growth medium for bacteria — amino acids are food — so a multi-dose vial without a preservative is an invitation to contamination.
| Bacteriostatic water | Sterile water for injection | |
|---|---|---|
| Contents | Sterile water + benzyl alcohol preservative | Sterile water only |
| Preservative | Yes — bacteriostatic (suppresses growth) | None |
| Vial entries | Multiple | Single use — use immediately, discard remainder |
| Beyond-use window after first entry | Up to 28 days | None — do not store after opening |
| Typical role | Multi-dose peptide reconstitution | One-time, use-the-whole-vial preparations |
Benzyl alcohol works by disrupting bacterial cell membranes and inhibiting the microbes' metabolic enzymes and protein synthesis; it is somewhat more active against Gram-negative bacteria than Gram-positive organisms and fungi, and works best below pH 5 (Stroppel 2023). It can also interact with the peptide itself: benzyl alcohol promoted aggregation of a therapeutic protein during reconstitution compared with water alone (Roy 2005), and the risk is greater for hydrophobic sequences near neutral pH — though the interactions are largely reversible and benzyl alcohol is gentler than other common preservatives such as phenol and m-cresol (Stroppel 2023). This is precisely the kind of per-product compatibility question a formulating pharmacy answers before dispensing, which is another reason the label governs.
Bacteriostatic Water for Injection, USP is sterile water containing a bacteriostatic preservative; a current U.S. label lists 0.9% or 1.1% benzyl alcohol and pH 4.5–7.0, while Hu 2023 explains why pH measurement in this low-ionic-strength product is difficult. Buy it through a pharmacy, not a mystery listing — and never substitute tap or drinking water, which carries minerals and contaminants no injection should contain.
What you need on hand
A reconstitution kit is short: the peptide vial, the diluent your pharmacy specified, syringes, needles, alcohol swabs, and a sharps container. Syringes of 1–3 mL cover typical volumes. Convention uses a larger 18–20 gauge needle for drawing and transferring the diluent, and a fine 27–31 gauge needle for the subcutaneous injection itself — prescription kits typically include the right supplies, so check what shipped before buying anything.
How to reconstitute peptides in six steps
The standard technique takes about five minutes of actual work plus a waiting period, and every step exists to protect a fragile molecule from heat, force, and contamination.
- Let everything reach room temperature. Take the peptide and diluent vials out of the refrigerator 20–30 minutes before mixing. A cold-against-warm mismatch can thermally shock the powder and cause clumping or precipitation.
- Swab both rubber stoppers with an alcohol wipe and let them air-dry for about 30 seconds. Do not blow on them or touch them afterward.
- Draw the volume of diluent your instructions specify (commonly 1–2.5 mL) into the syringe. Hold it needle-up, tap to gather air bubbles at the top, and press the plunger to expel them.
- Add the diluent slowly down the inside wall of the vial, needle angled away from the powder. Never spray the stream directly onto the cake — the sudden interfacial stress can cause foaming and damage the peptide's structure.
- Swirl gently. Never shake. After withdrawing the diluent syringe, pull back slightly on the plunger first to equalize the air pressure inside the vial.
- Inspect the result. Most peptides dissolve within 1–2 minutes of gentle swirling; some take 5–10 minutes. The solution should end up clear or very slightly hazy. Never heat the vial to hurry it — heat degrades peptides.
Follow the product-specific appearance instructions and contact the pharmacy rather than using a vial that does not match them; EGRIFTA WR labeling says not to use a solution that remains cloudy after a few seconds.
How concentration math works
The concentration of a reconstituted vial is the milligrams of peptide in the vial divided by the milliliters of diluent added. Add 2 mL to a 5 mg vial and you have 2.5 mg/mL; the same 5 mg in 1 mL would be 5 mg/mL. Volume then converts to syringe markings: on a standard U-100 insulin syringe, 1 mL equals 100 units, so 0.1 mL reads as 10 units. (Watch for a common internet arithmetic slip that calls 0.1 mL "100 units" — it is 10.)
Two practical notes. First, the diluent volume is a trade-off: more volume makes small amounts easier to measure precisely, while less volume wastes less diluent but magnifies any measurement error — which is why most instructions land in the 1–2.5 mL range. Second, use only the concentration and syringe-volume instructions supplied with the prescription, and ask the dispensing pharmacy to resolve any discrepancy. Elsayed 2025 reviews product-specific analytical quality control, not online calculators.
What this article deliberately does not contain is any dose. How many milligrams you draw, how often, and for how long is a prescription decision made by your provider for your specific product — the math above only tells you how to translate a prescribed dose into a syringe volume.
Storing a reconstituted vial
After mixing, follow the product-specific label for temperature, light protection, and disposal; requirements can differ substantially, including labeled room-temperature storage and a seven-day discard period. Stability after mixing also varies by product, so the printed instructions—not a general rule of thumb—set the usable window.
Do not freeze a reconstituted prescription peptide unless its product-specific instructions explicitly direct freezing; EGRIFTA WR, for example, says not to freeze the mixed product. Follow those instructions for storage and disposal. In this monoclonal-antibody study, one slow-freeze/fast-thaw cycle yielded 0.4% aggregates, while fast-freeze/slow-thaw yielded 3.2% after one cycle and 14.4% after three cycles; the 25 °C water-bath results also varied by fill volume (Jain 2021).
The diluent has its own rules: store unopened bacteriostatic water at controlled room temperature (20–25 °C) in its carton — ultraviolet light degrades benzyl alcohol — and never freeze it, since freezing can compromise the vial's seal. After first entry, store bacteriostatic water according to its label; a current U.S. label specifies 20–25 °C, and EGRIFTA WR's supplied bacteriostatic water remains at room temperature and is discarded 28 days after first use.
The chemistry your pharmacy handles for you
Behind every "just add the water slowly and swirl" instruction sits a set of formulation decisions that were made before your vial shipped, and they are the reason improvised recipes from forums are a bad idea. Not every peptide even dissolves in water: sequences that are more than about 50% nonpolar, or less than 25% charged, often need an organic co-solvent such as DMSO to dissolve at all, while strongly basic peptides go into 10–30% dilute acetic acid first and strongly acidic ones into 0.1% aqueous ammonia before gradual dilution — and DMSO must be avoided entirely for cysteine-containing peptides because it oxidizes their thiol groups; dimethylformamide (DMF) is the usual substitute there. Whatever the primary solvent, the working rule is to dissolve the peptide fully in it before any buffered salt solution is added, because salt meeting undissolved peptide can drive aggregation.
pH is a second lever. Formulation pH and buffer must be selected for the specific peptide; this review reports pH 3–5 as a preferred range for minimizing deamidation and gives peptide-specific examples of buffer effects (Nugrahadi 2023). And pH behavior can defy intuition — GLP-1, the native cousin of the compounded GLP-1 receptor agonists, reverses its aggregation kinetics between pH 7.5 and 8.0, which is why formulators screen empirically rather than trusting predictions (Zapadka 2017).
Even the container is a variable. At very low concentrations (around 1 micromolar), peptides stick to glass and plastic walls badly enough that 90% or more of the material can be lost (Kristensen 2015) — in one benchmark, only 10–20% of cationic peptides were recovered from a single standard container, approaching zero after transfer through four containers. Which surface behaves worst is unpredictable: recovery of the peptide ghrelin ranged from 20% in flint glass to 90% in polypropylene, and siliconized glass — intuitively the slick, safe choice — worsened losses to 46–53% for most peptides tested (Goebel-Stengel 2011). Laboratories counter this with low-binding polypropylene tubes, carrier proteins such as 0.1–1% BSA (which, combined with lyophilization in the best-suited tube, recovered over 89% of every peptide in that study's eight-peptide panel), 0.01–0.1% polysorbate 20, concentrated stocks of 0.5–2 nmol/µL diluted just before use, or 5–10% DMSO. At prescription concentrations in a properly chosen vial this is not something a patient manages — it is something the pharmacy already engineered around.
The degradation chemistry the storage rules protect against is well mapped: deamidation (accelerated above pH 6 and at higher temperatures), oxidation of methionine, cysteine, and tryptophan (driven by dissolved oxygen, trace metals, and light), hydrolysis of labile bonds under acidic conditions, and aggregation that begins at air-water and container-wall interfaces (Rahban 2023). Every rule in this article maps to one of those: swirl-don't-shake and no-foam protect the interfaces, refrigeration slows every reaction, the carton blocks light, and the dating limits total exposure time.
Before your first shipment arrives
Most of this article may turn out to be background: check whether your product ships as a powder kit or pre-mixed, read the pharmacy's instructions before opening anything, and keep the label's beyond-use date where you can see it. If you do reconstitute, the whole craft fits in one sentence — room temperature, down the wall, swirl gently, then follow the label for storage and dating. Questions about your specific product belong with your pharmacy; questions about whether a peptide therapy fits your situation belong with a provider. Peptide therapies through Promise are available only by prescription: a licensed provider reviews every request — not everyone qualifies, and a provider may decline.
This article is for educational purposes only and is not medical advice. Talk with a licensed healthcare provider about your individual health questions and before starting or stopping any treatment.